Devonian Health Group is trading at $9.81, with a +9.00% change as the broader biotech sector gains 2.75% during the September 2, 2026 session.
- No fresh company-specific announcement for September 2 was identified.
- Recent listing-related news remains a possible background sentiment factor: Devonian planned an NYSE American listing and concurrent underwritten offering, subject to final authorization.
- The move is best attributed to sector momentum rather than a confirmed company catalyst.